Cysteamine prevents and reverses the inhibition of pyruvate kinase activity caused by cystine in rat heart
- 28 June 2004
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1689 (2) , 114-119
- https://doi.org/10.1016/j.bbadis.2004.02.006
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- CystinosisPublished by Springer Nature ,2009
- Nephropathic cystinosis associated with cardiomyopathy: A 27-year clinical follow-upBMC Nephrology, 2002
- Immunolocalization of Cystinosin, the Protein Defective in CystinosisJournal of the American Society of Nephrology, 2002
- Cystinosin, the protein defective in cystinosis, is a H+-driven lysosomal cystine transporterThe EMBO Journal, 2001
- CTNS mutations in patients with cystinosisHuman Mutation, 1999
- Parenchymal organ cystine depletion with long-term cysteamine therapyBiochemical Medicine and Metabolic Biology, 1992
- Myopathy and Cystine Storage in Muscles in a Patient with Nephropathic CystinosisNew England Journal of Medicine, 1988
- ROLE OF REVERSIBLE OXIDATION-REDUCTION OF ENZYME THIOLS-DISULFIDES IN METABOLIC REGULATIONAnnual Review of Biochemistry, 1985
- Redox control of enzyme activities by thiol/disulfide exchangePublished by Elsevier ,1984
- Isozymes of pyruvate kinase in vertebrates: their physical, chemical, kinetic and immunological propertiesInternational Journal of Biochemistry, 1978